StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Invivyd's price to sales ratio was 3.0× on Nov 11, 2026, against 10.4× a year earlier. Over the last 2 years it ranged from 2.3× to 53.8×, with a median of 4.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.0×−7.6
2025Dec 31, 202510.6×+6.0
2024Dec 31, 20244.6×–

More Invivyd figures

See a number that looks wrong?